Your browser doesn't support javascript.
loading
Diagnosis of left ventricular hypertrophy using non-ECG-gated 15O-water PET.
Sörensen, Jens; Nordström, Jonny; Baron, Tomasz; Mörner, Stellan; Granstam, Sven-Olof; Lubberink, Mark; Tolbod, Lars; van den Berg, Jeffrey; Flachskampf, Frank A; Kero, Tanja; Magnusson, Peter; Harms, Hendrik J.
Afiliación
  • Sörensen J; Department of Surgical Sciences, Radiology & Nuclear Medicine, Uppsala University, Uppsala, Sweden. jens.sorensen@pet.uu.se.
  • Nordström J; PET Center, Entrance 86, Uppsala University Hospital, 751 85, Uppsala, Sweden. jens.sorensen@pet.uu.se.
  • Baron T; Department of Surgical Sciences, Radiology & Nuclear Medicine, Uppsala University, Uppsala, Sweden.
  • Mörner S; Centre for Research and Development, Region Gävleborg/Uppsala University, Gävle, Sweden.
  • Granstam SO; Department of Medical Sciences, Clinical Physiology and Cardiology, Uppsala University, Uppsala, Sweden.
  • Lubberink M; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Tolbod L; Department of Medical Sciences, Clinical Physiology and Cardiology, Uppsala University, Uppsala, Sweden.
  • van den Berg J; Department of Surgical Sciences, Radiology & Nuclear Medicine, Uppsala University, Uppsala, Sweden.
  • Flachskampf FA; Nuclear Medicine and PET, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Kero T; Department of Surgical Sciences, Radiology & Nuclear Medicine, Uppsala University, Uppsala, Sweden.
  • Magnusson P; Department of Medical Sciences, Clinical Physiology and Cardiology, Uppsala University, Uppsala, Sweden.
  • Harms HJ; Department of Surgical Sciences, Radiology & Nuclear Medicine, Uppsala University, Uppsala, Sweden.
J Nucl Cardiol ; 29(5): 2361-2373, 2022 Oct.
Article en En | MEDLINE | ID: mdl-34286452
ABSTRACT

AIM:

To develop a method for diagnosing left ventricular (LV) hypertrophy from cardiac perfusion 15O-water positron emission tomography (PET).

METHODS:

We retrospectively pooled data from 139 subjects in four research cohorts. LV remodeling patterns ranged from normal to severe eccentric and concentric hypertrophy. 15O-water PET scans (n = 197) were performed with three different PET devices. A low-end scanner (66 scans) was used for method development, and remaining scans with newer devices for a blinded evaluation. Dynamic data were converted into parametric images of perfusable tissue fraction for semi-automatic delineation of the LV wall and calculation of LV mass (LVM) and septal wall thickness (WT). LVM and WT from PET were compared to cardiac magnetic resonance (CMR, n = 47) and WT to 2D-echocardiography (2DE, n = 36). PET accuracy was tested using linear regression, Bland-Altman plots, and ROC curves. Observer reproducibility were evaluated using intraclass correlation coefficients.

RESULTS:

High correlations were found in the blinded analyses (r ≥ 0.87, P < 0.0001 for all). AUC for detecting increased LVM and WT (> 12 mm and > 15 mm) was ≥ 0.95 (P < 0.0001 for all). Reproducibility was excellent (ICC ≥ 0.93, P < 0.0001).

CONCLUSION:

15O-water PET might detect LV hypertrophy with high accuracy and precision.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Agua / Hipertrofia Ventricular Izquierda Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Agua / Hipertrofia Ventricular Izquierda Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article